Why this story

Why it matters
An antibody that protects infants through one transmission season could fill a gap early in life. To use it alongside routine vaccination, researchers need to know how long protection from each lasts when children receive both.
Attention gap
Ori’s seven-day headline-index search recorded 0 of 11 outlets with at least one relevant headline. Outside the Lead independently read specialist reporting in STAT and the conference organizer’s account. Index coverage varies by outlet.

One dose of the experimental antibody L9LS reduced the risk of malaria infection by 78% compared with placebo during a six-month malaria season in Mali, investigators reported at the American Society of Tropical Medicine and Hygiene meeting. The trial enrolled 180 infants aged one to 12 months.

When infants received the R21 malaria vaccine five months later, those who had received L9LS produced about 20% to 30% less of one vaccine-induced antibody than the placebo group. Researchers said they were pausing plans for a larger trial in infants. Whether the difference leaves vaccinated children more susceptible to malaria remains unknown.

What the evidence cannot tell us

  • Researchers presented preliminary results at a scientific meeting. The 78% estimate concerns infection during one season. The trial did not establish whether the lower antibody response reduced protection against illness after vaccination.

What to watch

Look for clinical follow-up on vaccinated children and a peer-reviewed report with the full trial results.

Read the sources. Credit the work.

The reporting and documents behind this brief, linked directly to the source. Verified publisher and author credits appear where available; other entries show their actual website address. Several links may draw on the same underlying reporting or research.

  1. American Society of Tropical Medicine and Hygiene, via Mirage News

    Mali Trial Finds Malaria Antibody Protects Infants but Blunts R21 Vaccine Response (opens in a new tab)

    miragenews.com · November 20, 2026

    Primary document / sourceContent read for this publication · November 22, 2026

    Publisher credit checked November 22, 2026. View credit on the source page (opens in a new tab).

  2. STAT

    Monoclonal antibody could interfere with malaria vaccine in babies (opens in a new tab)

    statnews.com · November 19, 2026

    Reporting / analysisContent read for this publication · November 22, 2026

    Publisher credit checked November 22, 2026. View credit on the source page (opens in a new tab).

This story was written and checked using AI against the linked evidence. No routine human review is claimed. Read the method.

Suggest an update or correction
Published corrections